JBJS - 2026-08-19 - Journal Article
Surgeon Ownership in the Ambulatory Arthroplasty Era: Preserving Transparency and Clinical Neutrality as Site-of-Service Shifts.
Siddiqi A, Jacob PB, Yousuf KM
Topics
Key Takeaway
Surgeon ASC equity ownership lacks standardized disclosure and risk-adjusted outcome reporting, creating unquantified conflicts of interest as arthroplasty site-of-service shifts accelerate.
Summary Depth
Choose how much analysis to show on this article page.
Summary
This opinion piece argues that current disclosure and benchmarking frameworks are inadequate for the era of surgeon-owned ASCs performing outpatient arthroplasty. As lower-risk patients migrate to ASCs and higher-risk patients remain hospital-based, unadjusted outcome comparisons systematically favor ASCs and obscure financial incentives. The authors propose four specific safeguards: standardized ownership disclosure, risk-adjusted site-of-service reporting, independent case review, and transparent equity life-cycle planning.
Key Limitation
The entire argument rests on theoretical conflict-of-interest risk; no outcome data, financial disclosures, or case-mix analyses are provided to demonstrate that biased case selection or patient harm is actually occurring.
Original Abstract
The rapid migration of total joint arthroplasty from hospitals to ambulatory surgery centers (ASCs) represents one of the most consequential structural changes in contemporary orthopaedics in the United States. In parallel, surgeon equity ownership in ASCs has expanded, aligning clinical decision-making with financial participation. Although surgeon ownership is legal, common, and often associated with efficiency and innovation, it introduces complex questions regarding transparency, case selection, and public trust. As higher-risk patients remain hospital-based while lower-risk patients migrate to ASCs, outcome comparisons may become distorted, and incentives may be less visible. Current disclosure practices and benchmarking frameworks have not evolved to reflect these structural shifts. This article argues that surgeon ownership in the ASC era necessitates updated safeguards, including standardized ownership disclosure, risk-adjusted site-of-service reporting, independent case review mechanisms, and transparent equity life-cycle planning. Proactive governance, rather than reactionary regulation, is essential to preserve professionalism and patient trust as ambulatory arthroplasty continues to expand.